Seattle Genetics' Hodgkin's lymphoma drug wins U.S. approval -—(Reuters) - U.S. regulators on Tuesday approved Seattle Genetics Inc's Adcetris as part of a chemotherapy cocktail to treat advanced Hodgkin's lymphoma in newly diagnosed patients, opening up a key market for the drugmaker.

U.S. beats Canada in shootout to win gold in women’s hockey. In the third consecutive meeting in the gold medal game between Team USA and Team Canada, the Americans finally got the better of their Canadian counterparts, defeating Canada, 3-2, in a shootout early Thursday morning.